Advertisement
New Zealand markets close in 30 minutes
  • NZX 50

    11,886.02
    +82.74 (+0.70%)
     
  • NZD/USD

    0.5945
    +0.0011 (+0.18%)
     
  • NZD/EUR

    0.5550
    +0.0009 (+0.16%)
     
  • ALL ORDS

    7,943.60
    +5.70 (+0.07%)
     
  • ASX 200

    7,688.00
    +4.50 (+0.06%)
     
  • OIL

    83.45
    +0.09 (+0.11%)
     
  • GOLD

    2,340.30
    -1.80 (-0.08%)
     
  • NASDAQ

    17,471.47
    +260.59 (+1.51%)
     
  • FTSE

    8,044.81
    +20.94 (+0.26%)
     
  • Dow Jones

    38,503.69
    +263.71 (+0.69%)
     
  • DAX

    18,137.65
    +276.85 (+1.55%)
     
  • Hang Seng

    17,110.21
    +281.28 (+1.67%)
     
  • NIKKEI 225

    38,403.91
    +851.75 (+2.27%)
     
  • NZD/JPY

    91.9660
    +0.2000 (+0.22%)
     

Company News For Dec 26, 2017

NantHealth, Inc. (NH) delivered earnings and revenue surprises of 23.08% and -10.83%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
  • Shares of Ignyta, Inc. RXDX surged 73% after the company announced that it had agreed to merge with Roche Holdings Inc.

  • NIKE, Inc. NKE shares plummeted 2.3% after posting second quarter 2018 earnings per share of $0.46, lower than $0.50  a share from the year ago quarter

  • Shares of Papa John's International, Inc. PZZA declined 3.9% after the company’s CEO John Schnatter announced that he was stepping down from the post

  • World Wrestling Entertainment, Inc’s WWE shares tumbled 7.3% after its CEO Vince McMahon sold about $100 million of his shares in the company to raise funds for a possible professional sports venture


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
World Wrestling Entertainment, Inc. (WWE) : Free Stock Analysis Report
 
Ignyta, Inc. (RXDX) : Free Stock Analysis Report
 
Papa John's International, Inc. (PZZA) : Free Stock Analysis Report
 
Nike, Inc. (NKE) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research